Interleukin-6 as a therapeutic target in advanced ovarian cancer. Background: Although the overall survival (OS) for advanced ovarian cancer (OC) is poor, patients (pts) who survive the initial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback